Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
66
LYEL Quote, Financials, Valuation and Earnings
Last price:
$38.65
Seasonality move
:
-22.7%
Day range:
$37.00 - $39.07
52-week range:
$7.65 - $45.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
139,971.51x
P/B ratio:
1.74x
Volume:
137.4K
Avg. volume:
79.2K
1-year change:
214.9%
Market cap:
$571.6M
Revenue:
$61K
EPS (TTM):
-$19.59
Earnings Data
Next earnings date for LYEL
Mar 11
2026
Most recent earnings per share
-$2.13
Missed by $2.13
(Nov 12/2025)
Consensus Estimate
--
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LYEL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/11/2026 | Q4 | -- | -- | -- | -- | -- |
| 11/12/2025 | Q3 | -- | $15K | -$2.13 | -- | -- |
| 08/12/2025 | Q2 | -- | $8K | -$2.89 | -- | -- |
| 05/13/2025 | Q1 | -- | $7K | -$0.18 | -- | -- |
| 03/11/2025 | Q4 | -- | $11K | -$14.40 | -$2.60 | -$11.80 |
| 11/07/2024 | Q3 | -- | $34K | -$0.17 | -- | -- |
| 08/07/2024 | Q2 | -- | $13K | -$0.18 | -- | -- |
| 05/06/2024 | Q1 | -- | $3K | -$0.24 | -$3.60 | $3.36 |
| 02/28/2024 | Q4 | -- | $13K | -$0.21 | -$4.10 | $3.89 |
| 11/07/2023 | Q3 | -- | $25K | -$0.20 | -- | -- |
| 08/08/2023 | Q2 | -- | $27K | -$0.26 | -- | -- |
| 05/04/2023 | Q1 | -- | $65K | -$0.27 | -- | -- |
| 02/28/2023 | Q4 | -- | $48.4M | -$0.03 | -- | -- |
| 11/08/2022 | Q3 | -- | $3K | -$0.28 | -- | -- |
| 08/04/2022 | Q2 | -- | $35.7M | -$0.15 | -- | -- |
| 05/10/2022 | Q1 | -- | $553K | -$0.28 | -- | -- |
| 02/28/2022 | Q4 | -- | $2.8M | -$0.34 | -- | -- |
| 11/12/2021 | Q3 | -- | $2.8M | -$0.20 | -- | -- |
| 08/12/2021 | Q2 | -- | $2.6M | -$0.26 | -- | -- |
| 03/31/2021 | Q1 | -- | $2.4M | -$0.22 | -- | -- |
| 12/31/2020 | Q4 | -- | $2.3M | -$3.67 | -- | -- |
| 09/30/2020 | Q3 | -- | $1.1M | -$0.15 | -- | -- |
| 06/30/2020 | Q2 | -- | $3.1M | -$0.42 | -- | -- |
| 03/31/2020 | Q1 | -- | $1.3M | -$0.13 | -- | -- |
Lyell Immunopharma, Inc. Earnings Questions
-
How Much did Lyell Immunopharma, Inc. Generate in Revenue Last Quarter?
Lyell Immunopharma, Inc. reported $15K worth of top line sales in its most recent quarter.
-
Did Lyell Immunopharma, Inc. Beat Earnings Last Quarter?
Lyell Immunopharma, Inc. announced earnings per share of -$2.13 which represents a miss of analyst forecast a -- per share.
-
Is Lyell Immunopharma, Inc. Profitable?
Lyell Immunopharma, Inc. reported -$2.6M that represents -$0.14 per share over the last quarter.
-
What is the Analyst Consensus for Lyell Immunopharma, Inc. EPS Next Year?
Lyell Immunopharma, Inc.'s earnings are forecast to decrease from -$26.23 per share to -$11.60 per share next year representing a decrease of -93.37%.
-
When is Lyell Immunopharma, Inc.'s Earnings Date?
Lyell Immunopharma, Inc.'s next earnings date is March 11, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
